Cite
HARVARD Citation
Kruger, S. et al. (n.d.). Expression of Indoleamine 2, 3-dioxygenase in erlotinib-treated patients with advanced pancreatic cancer: Translational results from a multi-center, randomized phase III trial. European journal of cancer. pp. S16-. [Online].